Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988;280(6):354-7.
doi: 10.1007/BF00426613.

Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes

Affiliations
Comparative Study

Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes

C Zachariae et al. Arch Dermatol Res. 1988.

Abstract

Epidermal lymphocyte chemotactic factor (ELCF) from skin overlying a positive tuberculin reaction was compared with the chemoattractants leukotriene B4 (LTB4), N-formyl-methionyl-leukyl-phenylalanine (FMLP), and complement split product C5a (C5a). The chemotactic assay used is a modified Boyden chamber technique. The lymphocytes were subsets of T lymphocytes from healthy young individuals first separated by flotation of E rosettes on Isopaque Ficoll followed by incubation of T cells with anti-CD4 and anti-CD8 monoclonal antibodies and further separation using fluorescence-activated cell sorting. ELCF specifically attracted OKT4+ lymphocytes, while LTB4, FMLP, and C5a induced significant migration in both OKT4+ and OKT8+ lymphocytes without any clear difference between the various chemoattractants or cell populations. We found no blocking of the chemotactic capacity of ELCF when we added antibodies towards IL-1 alpha and IL-1 beta to the chemotactic assay. Further recombinant IL-1 alpha and Il-1 beta did not induce any chemotactic response. Our observation may be of significance in explaining the predominance of OKT4+ cells in allergic contact dermatitis and certain other skin diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Invest Dermatol. 1985 Nov;85(5):431-3 - PubMed
    1. Clin Exp Immunol. 1985 Sep;61(3):526-34 - PubMed
    1. Arch Dermatol Res. 1988;280(2):83-8 - PubMed
    1. Acta Pathol Microbiol Immunol Scand C. 1985 Oct;93(5):189-93 - PubMed
    1. J Invest Dermatol. 1988 Feb;90(2):230-3 - PubMed

Publication types

MeSH terms

LinkOut - more resources